Is there an Acthar (H.P. Acthar Gel) generic version?
“Acthar” (H.P. Acthar Gel, repository corticotropin injection) does not have a widely available, interchangeable generic in the way people usually mean (a formally approved generic equivalent with an FDA “generic” label). The drug is typically discussed in terms of exclusivity and patent/licensing status rather than a standard generic launch. [1]
What does “generic Acthar” usually refer to?
People commonly use “generic Acthar” to mean one of these:
- A true FDA-approved generic (often called “equivalent” and expected to be substitutable)
- A biosimilar or follow-on product (for biologics, where naming and approval pathways differ)
- A product sold as a “replacement” that may not be the same FDA-rated generic-equivalent drug (so substitution rules can vary)
Without an FDA-designated generic-equivalent, payer policies often determine whether a non-Acthar product can be substituted. [1]
Why is Acthar hard to replace?
Acthar is a specific formulation of repository corticotropin. Replacing it is not as simple as copying a small-molecule drug, and market entry depends on the manufacturer’s ability to meet regulatory requirements and on remaining market exclusivity and patent positions. [1]
Are there alternative therapies instead of “Acthar generic”?
Depending on the condition being treated, clinicians may use other corticosteroids or other immune-modulating options rather than Acthar itself. Whether those options are clinically appropriate depends on the diagnosis, prior treatment response, and safety profile. (Your specific options depend on the indication your prescriber is treating.)
Pricing and insurance: what patients usually need to check
If you’re searching for “Acthar generic” because of cost, the most practical first steps are usually:
- Ask your prescriber if the indication has any approved alternatives that your plan covers.
- Call your insurer to ask whether your plan covers Acthar specifically and whether any substitution is allowed under your pharmacy benefit.
- Ask the pharmacy whether they can dispense any FDA-approved equivalent (if one exists for your plan/region).
Coverage decisions can hinge on “brand only” rules even when other corticotropin-related products exist in the marketplace. [1]
What to ask your doctor or pharmacist
If you’re trying to find the closest match to Acthar, ask:
- “Do you know of an FDA-approved generic-equivalent for Acthar for my diagnosis?”
- “If not, what covered alternatives does my plan prefer?”
- “Would changing therapies affect monitoring or dosing?”
If you tell me the condition being treated and your country (US, UK, etc.), I can narrow the likely options and what “generic” would mean there.
---
Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm (FDA Drug databases; use for checking whether an FDA-approved “generic” equivalent for Acthar exists and current status)